Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 112

    1.

    Hyperglycemia and stroke mortality: comparison between fasting and 2-h glucose criteria.

    Hyvärinen M, Qiao Q, Tuomilehto J, Laatikainen T, Heine RJ, Stehouwer CD, Alberti KG, Pyörälä K, Zethelius B, Stegmayr B; DECODE Study Group.

    Diabetes Care. 2009 Feb;32(2):348-54. Epub 2008 Nov 18.PMID: 19017775 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Hyperglycemia and incidence of ischemic and hemorrhagic stroke-comparison between fasting and 2-hour glucose criteria.

    Hyvärinen M, Tuomilehto J, Mähönen M, Stehouwer CD, Pyörälä K, Zethelius B, Qiao Q; DECODE Study Group.

    Stroke. 2009 May;40(5):1633-7. Epub 2009 Mar 12.PMID: 19286584 [PubMed - indexed for MEDLINE]Related articles

    3.

    Glucose tolerance and cardiovascular mortality: comparison of fasting and 2-hour diagnostic criteria.

    DECODE Study Group, the European Diabetes Epidemiology Group..

    Arch Intern Med. 2001 Feb 12;161(3):397-405.PMID: 11176766 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Is the current definition for diabetes relevant to mortality risk from all causes and cardiovascular and noncardiovascular diseases?

    DECODE Study Group, European Diabetes Epidemiology Group.

    Diabetes Care. 2003 Mar;26(3):688-96.PMID: 12610023 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Two prospective studies found that elevated 2-hr glucose predicted male mortality independent of fasting glucose and HbA1c.

    Qiao Q, Dekker JM, de Vegt F, Nijpels G, Nissinen A, Stehouwer CD, Bouter LM, Heine RJ, Tuomilehto J.

    J Clin Epidemiol. 2004 Jun;57(6):590-6.PMID: 15246127 [PubMed - indexed for MEDLINE]Related articles

    7.

    Two-hour glucose is a better risk predictor for incident coronary heart disease and cardiovascular mortality than fasting glucose.

    Qiao Q, Pyörälä K, Pyörälä M, Nissinen A, Lindström J, Tilvis R, Tuomilehto J.

    Eur Heart J. 2002 Aug;23(16):1267-75.PMID: 12175663 [PubMed - indexed for MEDLINE]Related articles

    8.

    From policemen to policies: what is the future for 2-h glucose? The Kelly West Lecture, 2000.

    Eschwège E, Charles MA, Simon D, Thibult N, Balkau B.

    Diabetes Care. 2001 Nov;24(11):1945-50.PMID: 11679462 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Postchallenge hyperglycemia and mortality in a national sample of U.S. adults.

    Saydah SH, Miret M, Sung J, Varas C, Gause D, Brancati FL.

    Diabetes Care. 2001 Aug;24(8):1397-402.PMID: 11473076 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Isolated postchallenge hyperglycemia and the risk of fatal cardiovascular disease in older women and men. The Rancho Bernardo Study.

    Barrett-Connor E, Ferrara A.

    Diabetes Care. 1998 Aug;21(8):1236-9.PMID: 9702426 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Hyperglycaemia and mortality from all causes and from cardiovascular disease in five populations of Asian origin.

    Nakagami T; DECODA Study Group.

    Diabetologia. 2004 Mar;47(3):385-94. Epub 2004 Feb 18.PMID: 14985967 [PubMed - indexed for MEDLINE]Related articles

    12.

    High blood glucose concentration is a risk factor for mortality in middle-aged nondiabetic men. 20-year follow-up in the Whitehall Study, the Paris Prospective Study, and the Helsinki Policemen Study.

    Balkau B, Shipley M, Jarrett RJ, Pyörälä K, Pyörälä M, Forhan A, Eschwège E.

    Diabetes Care. 1998 Mar;21(3):360-7.PMID: 9540016 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    The relationship of fasting plasma glucose values and other variables to 2-h postload plasma glucose in Japanese subjects.

    Bando Y, Ushiogi Y, Okafuji K, Toya D, Tanaka N, Fujisawa M.

    Diabetes Care. 2001 Jul;24(7):1156-60.PMID: 11423495 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Plasma glucose and prediction of microvascular disease and mortality: evaluation of 1997 American Diabetes Association and 1999 World Health Organization criteria for diagnosis of diabetes.

    Gabir MM, Hanson RL, Dabelea D, Imperatore G, Roumain J, Bennett PH, Knowler WC.

    Diabetes Care. 2000 Aug;23(8):1113-8.PMID: 10937507 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Comparison of a clinical model, the oral glucose tolerance test, and fasting glucose for prediction of type 2 diabetes risk in Japanese Americans.

    McNeely MJ, Boyko EJ, Leonetti DL, Kahn SE, Fujimoto WY.

    Diabetes Care. 2003 Mar;26(3):758-63.PMID: 12610034 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Continuous relationships between non-diabetic hyperglycaemia and both cardiovascular disease and all-cause mortality: the Australian Diabetes, Obesity, and Lifestyle (AusDiab) study.

    Barr EL, Boyko EJ, Zimmet PZ, Wolfe R, Tonkin AM, Shaw JE.

    Diabetologia. 2009 Mar;52(3):415-24. Epub 2009 Jan 8.PMID: 19130039 [PubMed - indexed for MEDLINE]Related articles

    19.

    Fasting and postchallenge glycemia and cardiovascular disease risk: the Framingham Offspring Study.

    Meigs JB, Nathan DM, D'Agostino RB Sr, Wilson PW; Framingham Offspring Study.

    Diabetes Care. 2002 Oct;25(10):1845-50.PMID: 12351489 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Progression to type 2 diabetes among high-risk groups in Kin-Chen, Kinmen. Exploring the natural history of type 2 diabetes.

    Chou P, Li CL, Wu GS, Tsai ST.

    Diabetes Care. 1998 Jul;21(7):1183-7.PMID: 9653617 [PubMed - indexed for MEDLINE]Related articlesFree article